腸內餵食配方市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、流程類型、階段、適應症、最終用途、地區和競爭細分，2020-2030 年

2024 年全球腸內餵食配方市場價值為 67.5 億美元，預計在預測期內將穩定成長，到 2030 年的複合年成長率為 6.75%。全球醫療保健產業正在經歷範式轉變，越來越關注整體病患照護。患者健康的關鍵方面是營養，對於因醫療條件而無法口服食物的人來說，腸內餵食配方已成為至關重要的解決方案。

全球腸內餵食配方市場在確保從早產兒到老年患者的個人獲得康復和整體健康所需的必需營養素方面發揮著關鍵作用。腸內餵食涉及透過管子將營養物質直接輸送到胃腸道。當個人因吞嚥障礙、消化問題或重症等情況而無法口服食物時，就會採用這種方法。腸內餵食配方，也稱為腸內營養或管飼配方，是含有均衡混合的常量營養素、維生素和礦物質的專門液體溶液。這些配方旨在滿足從嬰兒到成人的不同患者群體的特定營養需求。它們可分為多種類型，包括標準配方、特定疾病配方以及針對糖尿病或腎衰竭等特定醫療狀況的專門配方。世界上的老齡人口容易出現一系列健康問題，影響他們的正常飲食能力。這導致針對老年人營養需求的腸內餵食配方的需求增加。

關鍵市場促進因素

慢性病盛行率上升

主要市場挑戰

監管障礙和

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：腸內餵食配方市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品（標準配方、特定疾病配方）
  • 依流量類型（間歇供料流量、連續供料流量）
  • 依分期（成人、兒科）
  • 依適應症（阿茲海默症、營養不良、癌症照護、糖尿病、慢性腎臟病、孤兒病、吞嚥困難、疼痛管理、吸收不良/胃腸道疾病/腹瀉、其他）
  • 依最終用途（醫院、家庭護理）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美腸內餵食配方市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲腸內餵食配方市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太腸內餵食配方市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美腸內餵食配方市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲腸內餵食配方市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章：全球腸內餵食配方市場：SWOT 分析

第 14 章：競爭格局

• Abbott Laboratories Inc
• Danone SA
• Fresenius Kabi AG
• Nestle SA
• VICTUS Inc.
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

第 15 章：策略建議

第16章調查會社について,免責事項

Global Enteral Feeding Formulas Market was valued at USD 6.75 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 6.75% through 2030. The global healthcare industry is undergoing a paradigm shift, with a growing focus on holistic patient care. One essential aspect of patient well-being is nutrition, and for individuals who cannot consume food orally due to medical conditions, enteral feeding formulas have emerged as a crucial solution.

The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the essential nutrients they need for recovery and overall health. Enteral feeding involves providing nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals are unable to consume food orally due to conditions such as swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, ranging from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations for specific medical conditions like diabetes or renal failure. The world's aging population is prone to a range of health conditions that can affect their ability to eat normally. This has led to an increased demand for enteral feeding formulas tailored to the nutritional needs of the elderly.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global enteral feeding formulas market is witnessing substantial growth, primarily driven by the increasing prevalence of chronic diseases. In 2021, cardiovascular diseases remained the leading cause of mortality among non-communicable diseases (NCDs), accounting for at least 19 million deaths. Cancer followed closely, responsible for 10 million fatalities, while chronic respiratory diseases and diabetes contributed to 4 million and over 2 million deaths, respectively including kidney disease deaths linked to diabetes. Collectively, these four disease categories were responsible for 80% of all premature NCD-related deaths, underscoring their significant impact on global healthcare systems and the urgent need for targeted medical and nutritional interventions. As the global burden of conditions such as cancer, neurological disorders, diabetes, and gastrointestinal diseases continues to rise, the demand for enteral nutrition as a critical component of patient care is expanding. In 2020, cancer was a major global health burden, causing nearly 10 million deaths-equivalent to approximately one in every six fatalities worldwide. Chronic diseases often lead to conditions that impair normal eating and digestion, necessitating the use of enteral feeding formulas to ensure proper nutrient intake. For instance, cancer patients undergoing chemotherapy frequently experience severe appetite loss and gastrointestinal complications, making enteral nutrition essential for maintaining strength and immune function. Similarly, neurological disorders such as Parkinson's disease, multiple sclerosis, and stroke often cause dysphagia (difficulty swallowing), further driving demand for liquid-based nutritional support.

Key Market Challenges

Regulatory Hurdles and

One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.

Key Market Trends

Technological Advancements

Technological advancements in the field of enteral feeding formulas have touched various aspects of the market, revolutionizing both product development and administration methods. Technological innovations have enabled the development of highly specialized and nutritionally advanced enteral feeding formulas. These formulas are designed to cater to the specific nutritional requirements of patients with varying medical conditions, such as diabetes, renal failure, and gastrointestinal disorders. Through precise formulation and the inclusion of bioactive ingredients, these advanced formulas contribute to better patient recovery and improved overall health. Incorporation of cutting-edge delivery systems has revolutionized how enteral nutrition is administered. The development of pumps with programmable features has allowed for the precise delivery of enteral feeding formulas, ensuring that patients receive the required nutrients at the right rate and consistency. Such devices also minimize the risk of overfeeding or underfeeding, reducing potential complications. The integration of Internet of Things (IoT) technology has led to the creation of smart feeding pumps and monitoring devices. These devices can transmit real-time data about patients' nutritional intake, tube placement, and feeding progress to healthcare professionals.

Key Market Players

• Abbott Laboratories Inc
• Danone S.A
• Fresenius Kabi AG
• Nestle S.A.
• VICTUS Inc.
  • Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

Report Scope:

In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

• Standard Formula
• Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

• Intermittent Feeding Flow
• Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

• Adults
• Pediatrics

Enteral Feeding Formulas Market, By Indication:

• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Enteral Feeding Formulas Market, By End User:

• Hospitals
• Homecare

Enteral Feeding Formulas Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

Global Enteral Feeding Formulas Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Enteral Feeding Formulas Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
  • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
  • 5.2.3. By Stage (Adults, Pediatrics)
  • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
  • 5.2.5. By End-Use (Hospitals, Homecare)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Enteral Feeding Formulas Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Flow Type
  • 6.2.3. By Stage
  • 6.2.4. By Indication
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Enteral Feeding Formulas Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Flow Type
      • 6.3.1.2.3. By Stage
      • 6.3.1.2.4. By Indication
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Enteral Feeding Formulas Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Flow Type
      • 6.3.2.2.3. By Stage
      • 6.3.2.2.4. By Indication
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Enteral Feeding Formulas Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Flow Type
      • 6.3.3.2.3. By Stage
      • 6.3.3.2.4. By Indication
      • 6.3.3.2.5. By End User

7. Europe Enteral Feeding Formulas Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Flow Type
  • 7.2.3. By Stage
  • 7.2.4. By Indication
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Enteral Feeding Formulas Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Flow Type
      • 7.3.1.2.3. By Stage
      • 7.3.1.2.4. By Indication
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Enteral Feeding Formulas Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Flow Type
      • 7.3.2.2.3. By Stage
      • 7.3.2.2.4. By Indication
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Enteral Feeding Formulas Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Flow Type
      • 7.3.3.2.3. By Stage
      • 7.3.3.2.4. By Indication
      • 7.3.3.2.5. By End User
  • 7.3.4. France Enteral Feeding Formulas Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Flow Type
      • 7.3.4.2.3. By Stage
      • 7.3.4.2.4. By Indication
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Enteral Feeding Formulas Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Flow Type
      • 7.3.5.2.3. By Stage
      • 7.3.5.2.4. By Indication
      • 7.3.5.2.5. By End User

8. Asia-Pacific Enteral Feeding Formulas Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Flow Type
  • 8.2.3. By Stage
  • 8.2.4. By Indication
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Enteral Feeding Formulas Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Flow Type
      • 8.3.1.2.3. By Stage
      • 8.3.1.2.4. By Indication
      • 8.3.1.2.5. By End User
  • 8.3.2. India Enteral Feeding Formulas Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Flow Type
      • 8.3.2.2.3. By Stage
      • 8.3.2.2.4. By Indication
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Enteral Feeding Formulas Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Flow Type
      • 8.3.3.2.3. By Stage
      • 8.3.3.2.4. By Indication
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Enteral Feeding Formulas Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Flow Type
      • 8.3.4.2.3. By Stage
      • 8.3.4.2.4. By Indication
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Enteral Feeding Formulas Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Flow Type
      • 8.3.5.2.3. By Stage
      • 8.3.5.2.4. By Indication
      • 8.3.5.2.5. By End User

9. South America Enteral Feeding Formulas Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Flow Type
  • 9.2.3. By Stage
  • 9.2.4. By Indication
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Enteral Feeding Formulas Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Flow Type
      • 9.3.1.2.3. By Stage
      • 9.3.1.2.4. By Indication
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Enteral Feeding Formulas Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Flow Type
      • 9.3.2.2.3. By Stage
      • 9.3.2.2.4. By Indication
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Enteral Feeding Formulas Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Flow Type
      • 9.3.3.2.3. By Stage
      • 9.3.3.2.4. By Indication
      • 9.3.3.2.5. By End User

10. Middle East and Africa Enteral Feeding Formulas Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Flow Type
  • 10.2.3. By Stage
  • 10.2.4. By Indication
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Enteral Feeding Formulas Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Flow Type
      • 10.3.1.2.3. By Stage
      • 10.3.1.2.4. By Indication
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Flow Type
      • 10.3.2.2.3. By Stage
      • 10.3.2.2.4. By Indication
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Enteral Feeding Formulas Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Flow Type
      • 10.3.3.2.3. By Stage
      • 10.3.3.2.4. By Indication
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Enteral Feeding Formulas Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Danone S.A
• 14.3. Fresenius Kabi AG
• 14.4. Nestle S.A.
• 14.5. VICTUS Inc.
• 14.6. Primus Pharmaceuticals, Inc.
• 14.7. Meiji Holdings. Co Ltd.
• 14.8. Mead Johnson & Company, LLC

15. Strategic Recommendations

16. About Us & Disclaimer